D Hindley

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 211 citations · Full text

Medicine, Neurology, Pharmacology +17

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 191 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

A randomised study of "wet wraps" versus conventional treatment for atopic eczema

D Hindley · Archives of Disease in Childhood · 2005 · 68 citations · Full text

Medicine, Dermatology, Pediatrics +16

Diagnoses made in a secondary care "fits, faints, and funny turns" clinic

D Hindley · Archives of Disease in Childhood · 2006 · 48 citations · Full text

Medicine, Neurology, Pediatrics +14

Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · Health Technology Assessment · 2021 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14